HLB Pep Co., Ltd. (KOSDAQ:196300)
South Korea · Delayed Price · Currency is KRW 4,605.00
+265.00 (6.11%)
At close: Jun 29, 2026
HLB Pep Market Cap
HLB Pep has a market cap or net worth of 43.18 billion as of June 29, 2026. Its market cap has decreased by -49.44% in one year.
Market Cap
43.18B
Enterprise Value
35.20B
Revenue
5.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,605.00
Market Cap Chart
Since December 7, 2016, HLB Pep's market cap has decreased from 59.66B to 43.18B, a decrease of -27.62%. That is a compound annual growth rate of -3.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 43.18B | -35.11% |
| Dec 30, 2025 | 66.54B | -5.59% |
| Dec 30, 2024 | 70.48B | -19.25% |
| Dec 28, 2023 | 87.28B | 110.23% |
| Dec 29, 2022 | 41.51B | -51.73% |
| Dec 30, 2021 | 86.00B | 24.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 55.33B |
| TegoScience | 52.12B |
| Progen | 50.12B |
| Psomagen | 46.36B |
| Parataxis Korea | 44.13B |
| Aptamer Sciences | 44.01B |
| J2KBIO | 42.10B |
| Kainos Medicine | 35.56B |